| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | - | 14.0 | 23.2 | 1.0 | - | - | 38.2 |
| 1 | - | - | - | - | - | 19.5 | 44.8 | 0.8 | - | - | 65.0 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | 27.0 | 27.0 |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 140.5 |
| 1 | 146.8 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 23.2 |
| 1 | 0.8 |
| Number of post synapses: | 153 |
| Number of pre synapses: | 260 |
| Number of output connections: | 843 |
| Coverage factor: | 1.6 |
| Columnar completeness: | 0.06 |
| Area completeness: | 0.11 |
| Cell size (columns): | 26 |
| Number of post synapses: | 108 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 1.1 |
| Columnar completeness: | 0.04 |
| Area completeness: | 0.06 |
| Cell size (columns): | 8 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#aMe2 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | aMe5 (R) | ACh | 190 | 47.5 | 18.4% | 18.4% |
| 1 | MeLo1 (R) | ACh | 92 | 23.0 | 8.9% | 27.3% |
| 2 | MeVPMe12 (L) | ACh | 91 | 22.8 | 8.8% | 36.1% |
| 3 | MeVPaMe1 (L) | ACh | 73 | 18.2 | 7.1% | 43.2% |
| 4 | aMe12 (R) | ACh | 34 | 8.5 | 3.3% | 46.5% |
| 5 | MeLo3b (R) | ACh | 33 | 8.2 | 3.2% | 49.7% |
| 6 | aMe22 (R) | Glu | 30 | 7.5 | 2.9% | 52.6% |
| 7 | OA-AL2i3 (R) | OA | 24 | 6.0 | 2.3% | 54.9% |
| 8 | aMe8 (R) | ACh | 23 | 5.8 | 2.2% | 57.2% |
| 9 | Cm21 (R) | GABA | 23 | 5.8 | 2.2% | 59.4% |
| 10 | aMe4 (R) | ACh | 20 | 5.0 | 1.9% | 61.3% |
| 11 | Cm28 (R) | unclear | 20 | 5.0 | 1.9% | 63.3% |
| 12 | LT58 (R) | Glu | 20 | 5.0 | 1.9% | 65.2% |
| 13 | MeVPMe11 (L) | Glu | 20 | 5.0 | 1.9% | 67.2% |
| 14 | aMe2 (R) | Glu | 19 | 4.8 | 1.8% | 69.0% |
| 15 | MeVPaMe1 (R) | ACh | 16 | 4.0 | 1.6% | 70.5% |
| 16 | LoVP96 (R) | Glu | 15 | 3.8 | 1.5% | 72.0% |
| 17 | MeVPMe3 (L) | Glu | 15 | 3.8 | 1.5% | 73.4% |
| 18 | LoVP62 (R) | ACh | 12 | 3.0 | 1.2% | 74.6% |
| 19 | MeVC22 (R) | Glu | 11 | 2.8 | 1.1% | 75.7% |
| 20 | aMe17c (R) | Glu | 10 | 2.5 | 1.0% | 76.6% |
| 21 | Cm11a (R) | ACh | 10 | 2.5 | 1.0% | 77.6% |
| 22 | DNpe053 (L) | ACh | 10 | 2.5 | 1.0% | 78.6% |
| 23 | aMe30 (R) | Glu | 9 | 2.2 | 0.9% | 79.5% |
| 24 | TmY10 (R) | ACh | 9 | 2.2 | 0.9% | 80.3% |
| 25 | DNpe053 (R) | ACh | 8 | 2.0 | 0.8% | 81.1% |
| 26 | aMe10 (R) | ACh | 7 | 1.8 | 0.7% | 81.8% |
| 27 | aMe1 (R) | GABA | 6 | 1.5 | 0.6% | 82.4% |
| 28 | Cm11c (R) | ACh | 6 | 1.5 | 0.6% | 82.9% |
| 29 | LoVC23 (L) | GABA | 6 | 1.5 | 0.6% | 83.5% |
| 30 | MeLo6 (R) | ACh | 6 | 1.5 | 0.6% | 84.1% |
| 31 | aMe23 (R) | unclear | 5 | 1.2 | 0.5% | 84.6% |
| 32 | aMe6b (R) | ACh | 5 | 1.2 | 0.5% | 85.1% |
| 33 | LoVP9 (R) | unclear | 5 | 1.2 | 0.5% | 85.6% |
| 34 | MeVC21 (R) | Glu | 5 | 1.2 | 0.5% | 86.0% |
| 35 | MeVP14 (R) | ACh | 5 | 1.2 | 0.5% | 86.5% |
| 36 | Tm37 (R) | Glu | 5 | 1.2 | 0.5% | 87.0% |
| 37 | 5thsLNv_LNd6 (R) | ACh | 4 | 1.0 | 0.4% | 87.4% |
| 38 | aMe9 (R) | ACh | 4 | 1.0 | 0.4% | 87.8% |
| 39 | Cm4 (R) | Glu | 4 | 1.0 | 0.4% | 88.2% |
| 40 | Cm_unclear (R) | ACh | 4 | 1.0 | 0.4% | 88.6% |
| 41 | l-LNv (R) | unclear | 4 | 1.0 | 0.4% | 89.0% |
| 42 | MeVC20 (R) | Glu | 4 | 1.0 | 0.4% | 89.3% |
| 43 | MeVPaMe2 (L) | Glu | 4 | 1.0 | 0.4% | 89.7% |
| 44 | Mi10 (R) | ACh | 4 | 1.0 | 0.4% | 90.1% |
| 45 | Mi15 (R) | ACh | 4 | 1.0 | 0.4% | 90.5% |
| 46 | OCG02c (L) | unclear | 4 | 1.0 | 0.4% | 90.9% |
| instance | NT | total connections | connections /#aMe2 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | l-LNv (R) | unclear | 1,244 | 311.0 | 33.2% | 33.2% |
| 1 | 5thsLNv_LNd6 (R) | ACh | 405 | 101.2 | 10.8% | 44.0% |
| 2 | MeVPMe12 (R) | ACh | 182 | 45.5 | 4.9% | 48.8% |
| 3 | aMe1 (R) | GABA | 159 | 39.8 | 4.2% | 53.1% |
| 4 | aMe4 (R) | ACh | 156 | 39.0 | 4.2% | 57.2% |
| 5 | OA-AL2i3 (R) | OA | 153 | 38.2 | 4.1% | 61.3% |
| 6 | aMe26 (R) | ACh | 138 | 34.5 | 3.7% | 65.0% |
| 7 | Mi18 (R) | GABA | 131 | 32.8 | 3.5% | 68.5% |
| 8 | aMe5 (R) | ACh | 84 | 21.0 | 2.2% | 70.7% |
| 9 | aMe10 (R) | ACh | 77 | 19.2 | 2.1% | 72.8% |
| 10 | Cm35 (R) | GABA | 75 | 18.8 | 2.0% | 74.8% |
| 11 | Mi10 (R) | ACh | 75 | 18.8 | 2.0% | 76.8% |
| 12 | Tm5c (R) | Glu | 72 | 18.0 | 1.9% | 78.7% |
| 13 | aMe23 (R) | unclear | 37 | 9.2 | 1.0% | 79.7% |
| 14 | MeVC20 (R) | Glu | 37 | 9.2 | 1.0% | 80.7% |
| 15 | Cm8 (R) | GABA | 35 | 8.8 | 0.9% | 81.6% |
| 16 | Lawf1 (R) | ACh | 34 | 8.5 | 0.9% | 82.5% |
| 17 | Lat3 (R) | unclear | 32 | 8.0 | 0.9% | 83.4% |
| 18 | aMe12 (R) | ACh | 29 | 7.2 | 0.8% | 84.1% |
| 19 | Tm38 (R) | ACh | 28 | 7.0 | 0.7% | 84.9% |
| 20 | Cm34 (R) | Glu | 26 | 6.5 | 0.7% | 85.6% |
| 21 | SLP250 (R) | unclear | 25 | 6.2 | 0.7% | 86.2% |
| 22 | aMe3 (R) | Glu | 22 | 5.5 | 0.6% | 86.8% |
| 23 | MeVPMe12 (L) | ACh | 21 | 5.2 | 0.6% | 87.4% |
| 24 | MeVPaMe1 (R) | ACh | 20 | 5.0 | 0.5% | 87.9% |
| 25 | aMe2 (R) | Glu | 19 | 4.8 | 0.5% | 88.4% |
| 26 | SLP249 (R) | unclear | 19 | 4.8 | 0.5% | 88.9% |
| 27 | MeLo7 (R) | ACh | 18 | 4.5 | 0.5% | 89.4% |
| 28 | MeVP11 (R) | ACh | 17 | 4.2 | 0.5% | 89.9% |
| 29 | MeVP1 (R) | ACh | 16 | 4.0 | 0.4% | 90.3% |
| 30 | MeVPaMe1 (L) | ACh | 16 | 4.0 | 0.4% | 90.7% |
| 31 | l-LNv (L) | unclear | 15 | 3.8 | 0.4% | 91.1% |
| 32 | Tm36 (R) | ACh | 14 | 3.5 | 0.4% | 91.5% |
| 33 | Tm39 (R) | ACh | 14 | 3.5 | 0.4% | 91.9% |
| 34 | Lat1 (R) | unclear | 13 | 3.2 | 0.3% | 92.2% |
| 35 | MeVP29 (R) | ACh | 13 | 3.2 | 0.3% | 92.6% |
| 36 | MeVPMe13 (R) | ACh | 13 | 3.2 | 0.3% | 92.9% |
| 37 | MeVC22 (R) | Glu | 12 | 3.0 | 0.3% | 93.2% |
| 38 | aMe17a (R) | Glu | 11 | 2.8 | 0.3% | 93.5% |
| 39 | Tm5b (R) | ACh | 10 | 2.5 | 0.3% | 93.8% |
| 40 | aMe15 (R) | unclear | 8 | 2.0 | 0.2% | 94.0% |
| 41 | aMe17b (R) | GABA | 8 | 2.0 | 0.2% | 94.2% |
| 42 | aMe17c (R) | Glu | 8 | 2.0 | 0.2% | 94.4% |
| 43 | aMe30 (R) | Glu | 8 | 2.0 | 0.2% | 94.6% |
| 44 | Cm15 (R) | GABA | 8 | 2.0 | 0.2% | 94.9% |
| 45 | aMe9 (L) | ACh | 7 | 1.8 | 0.2% | 95.0% |
| 46 | MeVP63 (R) | GABA | 7 | 1.8 | 0.2% | 95.2% |
| 47 | TmY18 (R) | ACh | 7 | 1.8 | 0.2% | 95.4% |
| 48 | aMe9 (R) | ACh | 6 | 1.5 | 0.2% | 95.6% |
| 49 | CL125 (R) | unclear | 6 | 1.5 | 0.2% | 95.7% |
| 50 | Cm33 (R) | GABA | 6 | 1.5 | 0.2% | 95.9% |
| 51 | Lat5 (R) | unclear | 6 | 1.5 | 0.2% | 96.1% |
| 52 | MeVPaMe2 (L) | Glu | 6 | 1.5 | 0.2% | 96.2% |
| 53 | MeVP43 (R) | ACh | 5 | 1.2 | 0.1% | 96.3% |
| 54 | aMe13 (R) | unclear | 4 | 1.0 | 0.1% | 96.5% |
| 55 | aMe6b (R) | ACh | 4 | 1.0 | 0.1% | 96.6% |
| 56 | Cm11d (R) | ACh | 4 | 1.0 | 0.1% | 96.7% |
| 57 | Lat2 (R) | unclear | 4 | 1.0 | 0.1% | 96.8% |
| 58 | Li20 (R) | Glu | 4 | 1.0 | 0.1% | 96.9% |
| 59 | T2 (R) | ACh | 4 | 1.0 | 0.1% | 97.0% |